Epidermolysis bullosa acquisita

R Gupta, DT Woodley, M Chen - Clinics in dermatology, 2012 - Elsevier
Epidermolysis bullosa acquisita (EBA) is a rare, acquired, chronic subepidermal bullous
disease of the skin and mucosa characterized by autoantibodies to type VII collagen (C7) …

Clinical features and diagnosis of epidermolysis bullosa acquisita

A Vorobyev, RJ Ludwig, E Schmidt - Expert review of clinical …, 2017 - Taylor & Francis
Introduction: Epidermolysis bullosa acquisita (EBA) is a rare autoimmune blistering disease
of skin and mucous membranes. EBA is caused by autoantibodies against type VII collagen …

[HTML][HTML] Meta-analysis of the clinical and immunopathological characteristics and treatment outcomes in epidermolysis bullosa acquisita patients

H Iwata, A Vorobyev, H Koga, A Recke… - Orphanet journal of rare …, 2018 - Springer
Background Epidermolysis bullosa acquisita (EBA) is an orphan autoimmune disease.
Several clinical phenotypes have been described, but subepidermal blistering is …

Clinical, histological, immunological presentations and outcomes of bullous systemic lupus erythematosus: 10 New cases and a literature review of 118 cases

T de Risi-Pugliese, FC Aubart, J Haroche… - Seminars in arthritis and …, 2018 - Elsevier
Background Bullous systemic lupus erythematosus (BSLE) is a rare blistering condition
associated with systemic lupus erythematosus (SLE). Patients and methods We conducted a …

International Bullous Diseases Group: consensus on diagnostic criteria for epidermolysis bullosa acquisita

C Prost‐Squarcioni, F Caux, E Schmidt… - British Journal of …, 2018 - academic.oup.com
Background Epidermolysis bullosa acquisita (EBA) is a complex autoimmune bullous
disease disease with variable clinical presentations and multiple possible diagnostic tests …

Impact of serum cytokine levels on EEG-measured arousal regulation in patients with major depressive disorder and healthy controls

FM Schmidt, A Pschiebl, C Sander, KC Kirkby… - …, 2016 - karger.com
Background: In major depressive disorder (MDD), findings include hyperstable regulation of
brain arousal measured by electroencephalography (EEG) vigilance analysis and …

Epidermolysis bullosa acquisita: what's new?

N Ishii, T Hamada, T Dainichi… - The Journal of …, 2010 - Wiley Online Library
Type VII collagen is an adhesion molecule of the extracellular matrix in epithelial basement
membranes, and the main constituent of anchoring fibrils at the dermal–epidermal junction …

Sensitive and specific assays for routine serological diagnosis of epidermolysis bullosa acquisita

L Komorowski, R Müller, A Vorobyev, C Probst… - Journal of the American …, 2013 - Elsevier
BACKGROUND: Epidermolysis bullosa acquisita (EBA) is a severe autoimmune
subepidermal blistering disease characterized by autoantibodies against the N-terminal …

Epidermolysis bullosa acquisita: autoimmunity to anchoring fibril collagen

M Chen, GH Kim, L Prakash, DT Woodley - Autoimmunity, 2012 - Taylor & Francis
Epidermolysis bullosa acquisita (EBA) is a rare and acquired autoimmune subepidermal
bullous disease of skin and mucosa. EBA includes various distinct clinical manifestations …

Biology of anchoring fibrils: lessons from dystrophic epidermolysis bullosa

L Bruckner-Tuderman, B Höpfner, N Hammami-Hauasli - Matrix biology, 1999 - Elsevier
Anchoring fibrils are adhesive suprastructures that ensure the connection of the epidermal
basement membrane with the dermal extracellular matrix. The fibrils represent polymers of …